Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon gamma plus anidulafungin for candidemia
2009-014600-66Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2010
- Modality
- Cyclic Peptides → Modified Peptides → Peptides, Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in candidemia and invasive candidiasis comparing Interferon gamma + anidulafungin with Anidulafungin standard therapy alone (2 arms). Primary endpoint: Time to negative blood cultures. Started May 2010; status: completed.
02
Drugs
interferon gamma-1banidulafungin
03
Conditions
candidemiainvasive candidiasis
Beyond the preview
Go deeper on 2009-014600-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014600-66.